Co-expression of FAP and PSMA has been reported for various malignant tumors, including prostate, lung, colorectal, gastric, pancreatic, and thyroid cancers, as well as renal cell carcinomas, sarcomas, lymphomas, and other tumors [4,15,19]. This evidence concerns the gene FAP and cancer.